Luminal breast cancer identity is determined by loss of glucocorticoid receptor activity.

EMBO Mol Med · 2023 · PMC10701603 · PMID 37902007

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The C1 8‐gene classifier, derived from the PAM50 gene set, had a highly significant prognostic performance in luminal A patients found in the composite KMplot cohort (Figs 2I and EV3G ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.